[1]
“Comparative tolerability and efficacy of stavudine 30 mg versus stavudine 40 mg in patients on combination antiretroviral therapy in Kenya”, AJAHR, vol. 6, no. 1, pp. 75–82, Apr. 2018, Accessed: Oct. 28, 2026. [Online]. Available: https://kevinpage.org/index.php/AJAHR/article/view/1084